Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced a series of strategic governance ...
Discusses FDA Approval of TRYNGOLZA for Severe Hypertriglyceridemia and Acute Pancreatitis Risk Reduction June 24, ...
As you all know, Alnylam is pioneering an entirely new class of medicines to treat human disease. This generational technology leverages the mechanism of RNA interference, a natural process of gene ...
Explore the evolving landscape of male contraception, including novel nonhormonal pills and injectable hydrogels in clinical ...
No new commercial formulary additions or coverage decisions issued for neffy (epinephrine nasal spray) in the July 1, 2026 cycle; company to continue payer discussions for potential future inclusion ...
Mail’s Power 100 has ranked a cartoon dog ahead of the Prime Minister – and the full list of Queensland’s true powerbrokers ...
Amber Barkley is a writer and editor with over 10 years of experience in topics ranging from personal finance to marketing analytics to fiction. She found her niche in personal finance in 2022, when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results